Both tenascins interact with various chondroitin sulfate proteoglycans (CSPGs) of the lectican family such as versican and brevican and thus partake in the inhibitory environment that restricts regeneration of myelin, in particular in multiple sclerosis lesions [97,98,99]. This evidence concerns the gene BCAN and multiple sclerosis.